Flucloxacillin therapeutic drug monitoring in a neonate on extracorporeal membrane oxygenation
J Paediatr Child Health
.
2019 Feb;55(2):246-247.
doi: 10.1111/jpc.14333.
Authors
Laila S Al Yazidi
1
2
3
,
Sofia A Badran
4
,
Indy Sandaradura
5
6
,
Kevin Swil
2
7
,
Brendan McMullan
1
2
Affiliations
1
Immunology and Infectious Diseases Department, Sydney Children's Hospital, Sydney, New South Wales, Australia.
2
The School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia.
3
Sultan Qaboos University, College of Medicine, Muscat, Sultanate of Oman.
4
Infectious Diseases and Microbiology Department, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
5
Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia.
6
St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
7
Intensive Care Unit, Sydney Children's Hospital, Sydney, New South Wales, Australia.
PMID:
30746879
DOI:
10.1111/jpc.14333
No abstract available
Publication types
Letter
MeSH terms
Drug Monitoring*
Extracorporeal Membrane Oxygenation*
Floxacillin / administration & dosage*
Humans
Infant, Newborn
Substances
Floxacillin